Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
CureSign
CureSign Overview
Curesign is a medical device company aiming to disrupt the way oncologists treat patients with cancer. The companys solution is based on the integration of sensors with advanced signal-processing and big data tools. Curesigns product, which is in the advanced stages of development, is designed to allow clinical teams to tailor a patient-specific treatment for each cancer patient.
Curesigns technology has been successfully demonstrated in preclinical studies. Based on the results, the company is currently working on a commercial product for use in many preclinical trials in the field of oncology.